Table 1 Summary of T-MPs served as prophylactic tumor vaccines
From: Application of tumor microparticles in tumor prevention and treatment
Administration | Activated immunocytes | Prevented tumors | References |
|---|---|---|---|
s.c | DCs, T cells | s.c. H22, B16, CT26 | (Zhang et al. 2015) |
Oral | DCs, T cells | s.c. H22, B16, CT26 | (Dong et al. 2017) |
i.m. | Monocytes, macrophages, T cells | i.m. H22, B16, B16-OVA, CT26 | (Sun et al. 2023) |
i.v. | Neutrophils, macrophages | Metastatic LLC, B16 | (Zhai et al. 2022) |